Product image of Dervin (Diflucortolone Valerate) supplied by GNH India

Dervin

Active Ingredient:
Diflucortolone Valerate
Origin:
EU

Dervin (Diflucortolone Valerate)

Dervin is a topical medication containing diflucortolone valerate, used for skin conditions. It helps reduce inflammation and itching, offering relief for various dermatological issues.

Manufacturer / TM Owner

Bionativa S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Dervin is primarily used for cutaneous applications to alleviate symptoms of inflammatory skin conditions. It is often applied to reduce redness, swelling, and itching associated with eczema, psoriasis, and other dermatological disorders. The active ingredient, diflucortolone valerate, works by suppressing the inflammatory response in the skin.

Side Effects

  • When applied to the skin, Dervin may help reduce inflammation, itching, and redness. It is designed to provide localized relief, making it suitable for managing symptoms of various skin conditions. Users should follow the prescribed application guidelines for optimal results.

Precautions & Warnings

  • Dervin should be used as directed by a healthcare professional. Avoid contact with eyes and mucous membranes. Prolonged use or application to large areas of the skin should be avoided unless advised by a doctor. Always perform a patch test before extensive use to check for any adverse reactions.

Avoid Interactions

  • Dervin may interact with other topical medications. It is advisable to consult a healthcare provider before using it alongside other skin treatments. Additionally, avoid using it with products containing alcohol or other irritants, as this could increase the risk of skin irritation.

Frequently Asked Questions

Dervin is used for the treatment of inflammatory skin conditions, such as eczema and psoriasis, to reduce symptoms like itching and redness.

Dervin should be applied to the affected areas of the skin as directed by a healthcare professional. Always follow the prescribed application guidelines.

Dervin should be used with caution on sensitive skin. A patch test is recommended to check for any adverse reactions before extensive use.

Common side effects may include skin irritation, redness, or itching at the application site. Severe reactions are rare but should be reported to a healthcare provider.

Long-term use of Dervin should be monitored by a healthcare professional to avoid potential side effects or skin thinning.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Diflucortolone Valerate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT